Sanjeev Khindri Sells 4,134 Shares of Liquidia (NASDAQ:LQDA) Stock

Liquidia Corporation (NASDAQ:LQDA) insider Sanjeev Khindri sold 4,134 shares of the stock in a transaction that occurred on Monday, June 8th. The stock was sold at an average price of $65.46, for a total transaction of $270,611.64. Following the completion of the sale, the insider owned 67,132 shares in the company, valued at $4,394,460.72. This represents a 5.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Liquidia Stock Performance

NASDAQ LQDA opened at $71.63 on Friday. Liquidia Corporation has a 1 year low of $11.85 and a 1 year high of $72.49. The company has a debt-to-equity ratio of 1.18, a current ratio of 2.22 and a quick ratio of 2.03. The stock has a market capitalization of $6.37 billion, a PE ratio of 511.68 and a beta of 0.58. The company’s 50 day simple moving average is $49.18 and its two-hundred day simple moving average is $40.67.

Liquidia (NASDAQ:LQDA) last posted its earnings results on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.11. Liquidia had a net margin of 7.74% and a return on equity of 46.82%. The business had revenue of $132.87 million for the quarter, compared to analysts’ expectations of $119.44 million. Liquidia’s quarterly revenue was up 4187.1% compared to the same quarter last year. Analysts predict that Liquidia Corporation will post 2.97 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Zacks Research upgraded shares of Liquidia from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 5th. Jefferies Financial Group reiterated a “buy” rating and issued a $60.00 target price on shares of Liquidia in a research report on Monday, May 11th. Raymond James Financial reiterated a “strong-buy” rating and issued a $68.00 target price on shares of Liquidia in a research report on Thursday, June 4th. Wells Fargo & Company lifted their target price on shares of Liquidia from $51.00 to $62.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 12th. Finally, HC Wainwright lifted their target price on shares of Liquidia from $67.00 to $75.00 and gave the stock a “buy” rating in a research report on Friday, June 5th. Three research analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating and two have given a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $60.29.

Hedge Funds Weigh In On Liquidia

Large investors have recently added to or reduced their stakes in the business. Covestor Ltd increased its position in shares of Liquidia by 41.9% in the fourth quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after acquiring an additional 359 shares during the period. PNC Financial Services Group Inc. increased its position in shares of Liquidia by 7.2% in the fourth quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock valued at $217,000 after acquiring an additional 422 shares during the period. Quantinno Capital Management LP increased its position in shares of Liquidia by 3.6% in the first quarter. Quantinno Capital Management LP now owns 17,165 shares of the company’s stock valued at $648,000 after acquiring an additional 589 shares during the period. Northwestern Mutual Wealth Management Co. bought a new stake in shares of Liquidia in the fourth quarter worth about $25,000. Finally, ProShare Advisors LLC grew its stake in shares of Liquidia by 7.1% in the fourth quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock worth $405,000 after purchasing an additional 775 shares during the last quarter. Hedge funds and other institutional investors own 64.54% of the company’s stock.

About Liquidia

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).